# Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1) : Multi-centre, Prospective, Randomized Controlled Study

> **NCT00935194** · PHASE4 · COMPLETED · sponsor: **Capital Medical University** · enrollment: 102 (actual)

## Conditions studied

- Influenza

## Interventions

- **DRUG:** oseltamivir
- **OTHER:** blank
- **DRUG:** chinese medicinal herbs
- **DRUG:** oseltamivir and chinese medicinal herbs

## Key facts

- **NCT ID:** NCT00935194
- **Lead sponsor:** Capital Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 102 (ACTUAL)
- **Last updated:** 2009-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00935194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00935194, "Chinese Medicinal Herbs Treatment on Novel Influenza A (H1N1) : Multi-centre, Prospective, Randomized Controlled Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00935194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*